MedPath

Analysis of the effect of periodontal infectious disease on response to biological disease-modifying antirheumatic drug in patients with rheumatoid arthritis.

Not Applicable
Conditions
Periodontal disease, Rheumatoid arthritis
Registration Number
JPRN-UMIN000034665
Lead Sponsor
iigata University Medical and Dental Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

Having less than 15 teeth, the presenc e of pregnancy, history or the presence of any periodontal and antibiotic treatment within the previous 3 months.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease activity score including 28 joints (DAS28) after 6 months of medication.
Secondary Outcome Measures
NameTimeMethod
Tender joint count (TJC), Swollen joint count (SJC), and visual analogue scale (VAS) after 6 months of medication.
© Copyright 2025. All Rights Reserved by MedPath